Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting <scp>PI3K</scp>/<scp>AKT</scp>/<scp>mTOR</scp>/<scp>NF</scp>‐<scp>кB</scp> Signaling Pathway: <scp>TCGA</scp> Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment

Yu Xiang, Lingyun Xu, Chengming Hu et al.|Chemical Biology & Drug Design|2024

Cited by 2